← back to search

Chong‐Jen Yu

National Taiwan University Hospital · TW
Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies, and Tuberculosis Research and Epidemiology.
h-index
89
citations
37,334
works
961
NIH funding
primary concept
Medicine
email

Recent publications

Final analysis of the ZOE-LTFU trial to 11 years post-vaccination: efficacy of the adjuvanted recombinant zoster vaccine against herpes zoster and related complications
EClinicalMedicine 2025cited by 15position: middledoi
Alveolar epithelial cells mitigate neutrophilic inflammation in lung injury through regulating mitochondrial fatty acid oxidation
Nature Communications 2024cited by 38position: lastdoi
Adjuvant Osimertinib for Resected EGFR-Mutated Stage IB-IIIA Non–Small-Cell Lung Cancer: Updated Results From the Phase III Randomized ADAURA Trial
Journal of Clinical Oncology 2023cited by 380position: middledoi
LBA47 Osimertinib as adjuvant therapy in patients (pts) with resected EGFR-mutated (EGFRm) stage IB-IIIA non-small cell lung cancer (NSCLC): Updated results from ADAURA
Annals of Oncology 2022cited by 23position: middledoi
Postoperative Chemotherapy Use and Outcomes From ADAURA: Osimertinib as Adjuvant Therapy for Resected EGFR-Mutated NSCLC
Journal of Thoracic Oncology 2021cited by 149position: middledoi
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70
Clinical Infectious Diseases 2021cited by 93position: middledoi
Successful Treatment of a Critically Ill COVID-19 Patient Using Continuous Renal Replacement Therapy With Enhanced Cytokine Removal and Tocilizumab: A Case Report
Frontiers in Medicine 2021cited by 6position: middledoi
Osimertinib in Resected <i>EGFR</i> -Mutated Non–Small-Cell Lung Cancer
New England Journal of Medicine 2020cited by 1,723position: middledoi
Mitofusins regulate lipid metabolism to mediate the development of lung fibrosis
Nature Communications 2019cited by 175position: middledoi
SP110b Controls Host Immunity and Susceptibility to Tuberculosis
American Journal of Respiratory and Critical Care Medicine 2017cited by 45position: middledoi
Clinical activity of afatinib in patients with advanced non-small-cell lung cancer harbouring uncommon EGFR mutations: a combined post-hoc analysis of LUX-Lung 2, LUX-Lung 3, and LUX-Lung 6
The Lancet Oncology 2015cited by 978position: middledoi
R331W Missense Mutation of Oncogene <i>YAP1</i> Is a Germline Risk Allele for Lung Adenocarcinoma With Medical Actionability
Journal of Clinical Oncology 2015cited by 93position: middledoi
Interactions between household air pollution and GWAS-identified lung cancer susceptibility markers in the Female Lung Cancer Consortium in Asia (FLCCA)
Human Genetics 2015cited by 44position: middledoi
Intercalated combination of chemotherapy and erlotinib for patients with advanced stage non-small-cell lung cancer (FASTACT-2): a randomised, double-blind trial
The Lancet Oncology 2013cited by 304position: middledoi
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years
BMC Infectious Diseases 2013cited by 104position: middledoi
Genetic variant in TP63 on locus 3q28 is associated with risk of lung adenocarcinoma among never-smoking females in Asia
Human Genetics 2012cited by 42position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yi‐Long Wu · China Agricultural University5 papers (2015–2023)Masahiro Tsuboi · National Cancer Center Hospital East4 papers (2020–2023)Frances A. Shepherd · University Health Network4 papers (2020–2023)Charuwan Akewanlop · Siriraj Hospital4 papers (2020–2023)Thomas John · Austin Hospital4 papers (2020–2023)Filippo de Marinis · Istituto Oncologico Veneto4 papers (2020–2023)Jonathan W. Goldman · Industrial and Commercial Bank of China3 papers (2020–2023)Hữu Vĩnh Vũ · Cho Ray Hospital3 papers (2021–2023)Margarita Majem · Hospital de Sant Pau3 papers (2020–2023)Laura Bonanno · Louisiana State University3 papers (2020–2023)Kye Young Lee · Konkuk University Medical Center3 papers (2020–2023)К. К. Лактионов · Ministry of Health of the Russian Federation3 papers (2020–2023)Manuel Dómine · Hospital Universitario Fundación Jiménez Díaz3 papers (2020–2023)Terufumi Kato · Kanagawa Prefectural Hospital Organization3 papers (2020–2023)Sang-We Kim · Université Grenoble Alpes3 papers (2020–2023)Christian Grohé · Saarland University3 papers (2020–2023)Shun Lü · Central South University3 papers (2020–2023)Roy S. Herbst · Yale New Haven Hospital3 papers (2020–2023)Chia‐Lin Hsu · National Health Research Institutes2 papers (2019–2024)Augustine M.K. Choi · Weill Cornell Medicine2 papers (2019–2024)